2019 Ãß°èÇмú´ëȸ

2019³â Ãß°èÇмú´ëȸ´Â 8¿ù 30ÀÏ°ú 31ÀÏ ¾çÀÏ¿¡ °ÉÃÄ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü¿¡¼­ °³ÃֵǾú´Ù.

±Ý¹ø Ãß°èÇмú´ëȸ¿¡´Â ÃÑ 342¸íÀÌ Âü¼®ÇÏ¿© °©»ó¼±°ü·Ã ¿¬±¸ÀÇ ¼º°øÀûÀÎ ±³·ùÀÇ ÀåÀÌ µÇ¾ú´Ù. Education session, symposium, presidential lecture, AOTA prize plenary lecture, meet the professor, ¿¬±¸À§¿øȸ, luncheon symposium, °£È£»ç session, Topic highlights, ÀÚÀ¯¿¬Á¦ ¹ßÇ¥·Î ³ª´µ¾î ÁøÇàµÇ¾ú´Ù.

Education sessionÀ¸·Î Revised ATA guideline ¿¡¼­µµ °­Á¶µÈ °©»ó¼± ¼ö¼úÀü preoperative, intraoperative evaluation ¿¡ ´ëÇÑ ³»¿ëÀ¸·Î vocal cord evaluation, neuromonitoring ±×¸®°í surgeon ÀÌ ½ÃÇàÇÏ´Â intraoperative Ultrasonogram µî ½ÇÁ¦ ÀÓ»ó¿¡¼­ Àû¿ëÇÒ ¼ö ÀÖ´Â ³»¿ëÀ» Áß½ÉÀ¸·Î °­ÀÇ°¡ ÁøÇàµÇ¾ú´Ù. ¶ÇÇÑ ÀÇ·á & ÀÚ¿¬¹æ»ç¼±°ú °©»ó¼±À̶ó´Â ÁÖÁ¦·Î ¹æ»ç¼± ¹× RAI, ÇÙÀÇÇа˻翡 ÀÇÇÑ ¹æ»ç¼± ³ëÃâ°ú secondary malignancy ¿¡ ´ëÇØ ÀÇ·áÁø »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚµéÀÇ ¸·¿¬ÇÑ ºÒ¾È°¨À» ÇØ¼Ò ÇÒ ¼ö ÀÖ´Â ±âȸ°¡ µÇ¾ú´Ù.

symposiumÀº Å©°Ô CNB Áø·á Áöħ °¡À̵å¶óÀÎ, precision medicine in thyroid cancer treatment, management of locally advanced thyroid cancer, bioinformatic approaches of TCGA thyroid cancer, staging evaluation based on Imaging ±×¸®°í ÅëÇÕ symposium À¸·Î update on the management of Graves diseaseÀ¸·Î ³ª´µ¾î ÁøÇàµÇ¾ú´Ù.

core needle biopsy session Àº ¼¼Ä§ ÈíÀÎ °Ë»ç¿¡ ºñÇØ core needle biopsy°¡ °¡Áö´Â Áø´ÜÀÇ À¯¿ë¼º¿¡ ´ëÇÑ ³»¿ë ¹× À̸¦ ±â¼úÇϱâ À§ÇÑ Áø´Ü º¸°í¼­ÀÇ Ç¥ÁØÈ­¿¡ ´ëÇÑ °­ÀÇ°¡ ÀÌ·ç¾îÁ® ¹Ýº¹ÀûÀÎ ¼¼Ä§ ÈíÀÎ °Ë»ç¿¡µµ °á·Ð¿¡ µµ´ÞÇϱ⠾î·Á¿î indeterminate nodule ÀÇ Áø·á¿¡ µµ¿òÀÌ µÈ °ÍÀ¸·Î »ý°¢µÇ¾ú´Ù.

Graves disease Ä¡·á¿¡ ´ëÇÑ ÅëÇÕsymposium À¸·Î ³»°ú, ÇÙÀÇÇаú, ¿Ü°úÀû °ßÇØ¿Í ¾Èº´Áõ¿¡ ´ëÇÑ ÀÌÇظ¦ ³ô¿©, ȯÀÚ¸¦ À§ÇØ ¸ÂÃãÇü Ä¡·á ¹æ¹ýÀ» °øÀ¯ ÇÒ ¼ö ÀÖ´Â ½Ã°£ÀÌ µÇ¾ú´Ù.

Precision medicine in Thyroid cancer treatment ¿¡¼­´Â »ï¼º ¼­¿ïº´¿ø°ú ¼­¿ï´ëÇб³¿¡¼­ ÁøÇàÁßÀÎ cancer panel ¿¡ ´ëÇÑ ¿¬±¸ °á°ú¸¦ °øÀ¯ÇÒ ¼ö ÀÖ¾ú°í, bioinformatics session ¿¡¼­´Â ¿¬±¸ÀÚµéÀÌ ¸¹Àº °ü½ÉÀ» °®°í´Â ÀÖÁö¸¸ ½±°Ô µµÀüÇÏÁö ¸øÇß´ø TCGA data¸¦ Àû¿ëÇÏ´Â ½ÇÁúÀûÀÎ ¹æ¹ý¿¡ ´ëÇØ ¿©·¯ °¡Áö ³ëÇϿ츦 Àü´ÞÇÏ´Â ±ÍÇÑ ½Ã°£ÀÌ µÇ¾ú´Ù.

meet the professor session¿¡¼­´Â Á¤ÀçÈÆ ±³¼ö´Ô²²¼­ "ÀӽŰú °©»ó¼±"À» ÁÖÁ¦·Î ÀӽŰú °ü·ÃµÈ °©»ó¼±ÀÇ »ý¸®Àû º¯È­¿Í ÀÌÀÇ ¿Ã¹Ù¸¥ °Ë»ç °á°úÀÇ Çؼ®, Ä¡·á¿¡ ´ëÇØ ¾Ë±â ½±°Ô °­ÀÇÇØ ÁÖ¼ÌÀ¸¸ç, Presidential lecture·Î´Â ÀÌÀçÅ ±³¼ö´Ô²²¼­ "¹æ»ç¼º ¿ä¿Àµå¿Í °©»ó¼± ¾Ï: °ú°Å, ÇöÀç ±×¸®°í ¹Ì·¡"¸¦ ÁÖÁ¦·Î °©»ó¼± ¾Ï Ä¡·á¿¡ À־ ¹æ»ç¼º ¿ä¿ÀµåÄ¡·áÀÇ ¿ª»ç ¹× ÃֽŠ°æÇâ¿¡ ´ëÇÏ¿© dzºÎÇÑ °æÇèÀ» °øÀ¯ÇÏ¿© ÁÖ¾ú´Ù.

AOTA prize plenary lecture ´Â ±è¿ø¹è ±³¼ö´Ô²²¼­ "unmet clinical needs in the management of patients with thyroid cancer"¶ó´Â ÁÖÁ¦·Î °©»ó¼± ¾Ï Ä¡·á ºÐ¾ß¿¡¼­ ¾ÆÁ÷ ÇØ°áµÇÁö ¾ÊÀº ¹®Á¦¿¡ ´ëÇØ ¿©·¯ ´ë¾ÈÀ» Á¦½ÃÇÏ¿´´Ù.

¿¬±¸À§¿øȸ¿¡¼­´Â microRNA°¡ diagnostic ȤÀº therapeutic target À¸·Î »ç¿ëµÇ´Â ÃֽŠÁö°ßµéÀ» ¼Ò°³ÇÔÀ¸·Î½á ¿¬±¸ÀÚµéÀÌ °©»ó¼± ¾Ï¿¡ ÀÖ¾î microRNA ÀÇ Àû¿ë¿¡ ´ëÇØ ¾ÆÀ̵ð¾î¸¦ ¾òÀ» ¼ö ÀÖ´Â ¼ÒÁßÇÑ ½Ã°£ÀÌ µÇ¾úÀ¸¸ç, °£È£»ç session ¿¡¼­´Â °©»ó¼± ÁúȯÀ» °¡Áø ȯÀڵ鿡°Ô µµ¿òÀ» ÁÙ ¼ö ÀÖ´Â ¹«±âÁú ¹× ¿µ¾ç °ü¸®¿¡ ´ëÇÑ °­ÀÇ·Î ¾ËÂ÷°Ô ±¸¼ºµÇ¾ú´Ù.

2019³â ´ëÇÑ°©»ó¼±ÇÐȸ Àӻ󿬱¸»óÀº ¼­¿ïÀÇ´ë ¹®ÀçÈÆ ±³¼ö°¡ "Clinical usefulness of a web solution detecting recurrence of Graves' disease with biosignals from wearable devices in the patients who discontinue anti-thyroidal drugs", °æºÏÀÇ´ë ÀÌÀçÅ ±³¼ö°¡ "Multi-center retrospective study of development of secondary malignancy after radioiodine therapy in thyroid cancer patients", ÀþÀº ¿¬±¸ÀÚ»óÀº ¼­¿ïÀÇ´ë Á¶¼±¿í ±³¼ö°¡ "Effects of excessive maternal iodine intake during pregnancy on fetal and infant developments", ÀþÀº ¿¬±¸ÀÚ»ó Ưº°»óÀº Â÷ÀÇ°ú´ëÇÐ ¼Û¿µ½Å ±³¼ö°¡ "Identification of targetable alterations by the analysis of cancer evolution and heterogeneity in anaplastic thyroid cancer" À¸·Î °¢°¢ ¼ö»óÇÏ¿´´Ù. ¶ÇÇÑ ÃÖ¿ì¼ö ¿¬Á¦»óÀº °¡Å縯ÀÇ´ë Á¤Âù±Ç ±³¼ö°¡ "Comprehensive DNA methylation profiling identifies novel diagnostic biomarkers for thyroid cancer", ¼­¿ïÀÇ´ë ÀÌ¿µ¾Æ ±³¼ö°¡ "Genetic alterations and molecular characteristics in pediatric papillary thyroid carcinoma"À¸·Î ¼ö»óÇÏ¿´´Ù.



°¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¿Ü°ú À̼ÒÈñ